(Q37149427)

18 August 2017

1 reference

title

Malignancy in kidney transplant recipients (English)

1 reference

18 August 2017

Anil Kapoor

1

1 reference

18 August 2017

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

68 Suppl 1

1 reference

18 August 2017

11-19

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200868001-00003

18 August 2017

0 references

cites work

Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200868001-00003

Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study

21 January 2018

1 reference

12 December 2020

Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study

1 reference

12 December 2020

Basiliximab: a review of its use as induction therapy in renal transplantation

1 reference

12 December 2020

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

1 reference

12 December 2020

Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice

1 reference

12 December 2020

Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF.

1 reference

12 December 2020

De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation.

1 reference

12 December 2020

Rituximab in association with rapamycin for post-transplant lymphoproliferative disease treatment

1 reference

12 December 2020

Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients

1 reference

12 December 2020

Possible association of the immunosuppressive and B cell lymphoma-promoting properties of cyclosporine

1 reference

12 December 2020

Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies

1 reference

12 December 2020

Malignancies in organ transplant recipients

1 reference

12 December 2020

Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during a 25-year period

1 reference

12 December 2020

Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growth

1 reference

12 December 2020

Malignancy after transplantation

1 reference

12 December 2020

Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma

1 reference

12 December 2020

Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer

1 reference

12 December 2020

Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation

1 reference

12 December 2020

Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients

1 reference

12 December 2020

Mycophenolate mofetil modulates adhesion receptors of the beta1 integrin family on tumor cells: impact on tumor recurrence and malignancy

1 reference

12 December 2020

Mycophenolate mofetil increases adhesion capacity of tumor cells in vitro

1 reference

12 December 2020

Identifying High Risk Groups and Quantifying Absolute Risk of Cancer After Kidney Transplantation: A Cohort Study of 15 183 Recipients

1 reference

12 December 2020

Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma

1 reference

12 December 2020

Long-term toxicity of antithymocyte globulin induction may vary with choice of agent: a single-center retrospective study.

1 reference

12 December 2020

Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin

1 reference

12 December 2020

mTOR inhibition and its effect on cancer in transplantation

1 reference

12 December 2020

Effects of immunosuppressive therapy on the induction of skin tumors by ultraviolet irradiation in hairless mice

1 reference

12 December 2020

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

1 reference

12 December 2020

Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies

1 reference

12 December 2020

Rapamycin is an effective inhibitor of human renal cancer metastasis.

1 reference

12 December 2020

Cancer after kidney transplantation in the United States

1 reference

12 December 2020

Nitric oxide modulates vascular endothelial growth factor and receptors in chronic cyclosporine nephrotoxicity

1 reference

12 December 2020

Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy

1 reference

12 December 2020

Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas

1 reference

12 December 2020

One thousand renal transplants at Belfast City Hospital: post-graft neoplasia 1968-1999, comparing azathioprine only with cyclosporin-based regimes in a single centre

1 reference

12 December 2020

Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation

1 reference

12 December 2020

Post-transplant de novo malignancies in renal transplant recipients: the past and present

1 reference

12 December 2020

Incidence of cancer after kidney transplant: results from the North Italy transplant program

1 reference

12 December 2020

Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression

1 reference

12 December 2020

Safety of mycophenolate mofetil versus azathioprine in renal transplantation: a systematic review

1 reference

12 December 2020

Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma

1 reference

12 December 2020

Sirolimus for Kaposi's sarcoma in renal-transplant recipients

1 reference

12 December 2020

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

1 reference

12 December 2020

Cancer incidence before and after kidney transplantation

1 reference

12 December 2020

Non-melanoma skin cancers and glucocorticoid therapy

1 reference

12 December 2020

Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor

1 reference

12 December 2020

Activity of rapamycin (AY-22,989) against transplanted tumors

1 reference

12 December 2020

Sirolimus: its discovery, biological properties, and mechanism of action

1 reference

12 December 2020

Long-term patient survival: strategies to improve overall health

1 reference

12 December 2020

The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders

1 reference

12 December 2020

Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

1 reference

12 December 2020

10.2165/00003495-200868001-00003

Identifiers

DOI

1 reference

PubMed ID

18442297

Dimensions Publication ID

18 August 2017

1036869158

0 references

Fatcat ID

release_kfirr77zina7dmxbp7qorqe5ae

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kfirr77zina7dmxbp7qorqe5ae

24 November 2022

mapped directly with Wikidata item

PubMed ID

18442297

1 reference

PubMed ID

18442297